Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.

Losartan Market Expansion Outlook: What Revenue Opportunities Lie Ahead?

The market for losartan has experienced consistent expansion, projected to increase from $1.49 billion in 2025 to $1.55 billion in 2026, reflecting a compound annual growth rate of 4.2%. This growth trajectory in the historical period is largely attributable to the escalating global prevalence of hypertension, the broad clinical acceptance of angiotensin II receptor blockers (ARBs), a rise in diabetes-induced kidney illnesses, heightened public consciousness regarding cardiovascular risk mitigation, and a discernible shift from ACE inhibitors to ARBs for treatment.

The global losartan market is projected to experience consistent expansion, reaching an estimated value of $1.83 billion by 2030 with a compound annual growth rate of 4.3%. This anticipated growth trajectory is fueled by several key factors, including an increasing elderly demographic, a heightened demand for antihypertensive medications that safeguard kidney function, broadened availability of cost-effective generic versions, a greater emphasis on preventing strokes, and increased healthcare expenditures dedicated to managing chronic conditions. Within this forecast period, significant market dynamics are expected to include a rise in hypertension and cardiovascular ailments, a discernible shift favoring angiotensin II receptor blockers (ARBs) over angiotensin-converting enzyme (ACE) inhibitors, a surge in prescriptions for generic losartan, its growing application in managing diabetic nephropathy, and a greater adoption of long-term blood pressure management strategies.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24284&type=smp

Losartan Market Industry Drivers: What Is Driving Revenue Growth?

The increasing frequency of hypertension is anticipated to drive the expansion of the losartan market in the future, as this condition, characterized by consistently elevated blood pressure, significantly heightens the risk of cardiovascular ailments, cerebrovascular incidents, and other grave health issues, with its rising occurrence often associated with diets high in sodium and processed items that promote fluid retention and cardiac stress, and losartan functions to manage hypertension by obstructing angiotensin II, a hormone responsible for blood vessel constriction, thereby facilitating vessel relaxation and dilation, consequently reducing blood pressure and alleviating the heart’s exertion; for example, data from the Centers for Disease Control and Prevention indicated that in 2023, hypertension was a direct or contributing factor in 664,470 fatalities within the United States, underscoring the direct correlation between the escalating prevalence of hypertension and the burgeoning losartan market.

Losartan Market Segmentation Trends And Revenue Drivers

The losartan market covered in this report is segmented –

1) By Dosage: Tablet, Powder, Suspension

2) By Source: Contract Manufacturing Organizations, In-House

3) By Distribution Channel: Online, Offline

4) By Application: Hypertension, Stroke, Diabetic Nephropathy, Other Applications

5) By End-User: Adult, Pediatric

Subsegments:

1) By Tablet: 25 Milligrams (mg), 50 Milligrams (mg), 100 Milligrams (mg)

2) By Powder: 25 Milligrams (mg), 50 Milligrams (mg), 100 Milligrams (mg)

3) By Suspension: 5 Milligrams (mg) Per 5 Milliliters (mL), 10 Milligrams (mg) Per 5 Milliliters (mL), 25 Milligrams (mg) Per 5 Milliliters (mL)

#Losartan Market Growth Trends: What Is Influencing The Future Outlook?

To address patient needs and broaden treatment possibilities within the losartan market, leading manufacturers are prioritizing the creation of novel products and securing necessary authorizations, exemplified by the introduction of losartan potassium oral suspension. This liquid rendition of losartan potassium is designed specifically for those who find swallowing pills challenging. A case in point is Scienture Holdings Inc., a pharmaceutical enterprise based in the United States, which obtained approval from the Food and Drug Administration (FDA) in March 2025 for Arbli. This pre-prepared liquid treatment targets hypertension, aims to decrease stroke risk in hypertensive individuals experiencing left ventricular hypertrophy, and addresses diabetic nephropathy in patients with type 2 diabetes, providing accurate dosages without the need for specialized preparation and maintaining an eighteen-month stability at ambient temperatures in a 165 mL peppermint-flavored suspension containing 10 mg/mL.

Losartan Market Industry Leaders: Which Organizations Are Driving Competition?

Major companies operating in the losartan market are Viatris Inc., Teva Pharmaceutical Industries Ltd, Intas Pharmaceuticals Ltd., Sun Pharmaceutical Industries Ltd., Apotex Inc., Aurobindo Pharma Ltd., Dr. Reddy’s Laboratories Ltd., Cipla Ltd., Cadila Pharmaceuticals Ltd., Lupin Ltd., Zydus Lifesciences Ltd., Torrent Pharmaceuticals Ltd., Alembic Pharmaceuticals Ltd., Vasudha Pharma Chem Ltd., Unichem Laboratories Ltd., Global Pharma Tek, Manus Aktteva Biopharma LLP, Emcure Pharmaceuticals Ltd., Wellona Pharma, JPM Pharma & Chemicals Pvt. Ltd.

Access The Complete Losartan Market Report:

https://www.thebusinessresearchcompany.com/report/losartan-global-market-report

Losartan Market Largest Region: Which Geography Holds The Highest Market Share?

North Americawas the largest region in the losartan market in 2025. Asia-Pacificis expected to be the fastest-growing region in the forecast period. The regions covered in the losartan market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model